Abstract:Objective To investigate the apoptosis-inducing effect of peroxisome proliferator-activated receptor γ (PPARγ) agonist ciglitazone (CGZ)on leukemic HL-60 cells and its mechanisms of action. Methods HL-60 cells in vitro culture medium were subject to different concentrations of CGZ (10-50 μmol/L) for 24, 48 and 72 h. MTT assay was used to detect the cell inhibitory rate and agarose gel electrophoresis to observe DNA fragmentation. Flow cytometry (FCM) and Annexin V/PI staining were used to detect CGZ and/or GW9662 ( PPARγ antagonist)-induced cell apoptosis. The expression of PPARγ was examined by RT-PCR and Western bloting. The caspase-3 and protein levels in mitogen-activated protein kinase signaling pathways (MAPKs, p-P38, p-ERK and p-JNK) were also detected. Results CGZ (over 30 μmol/L) could inhibit the growth of HL-60 cells in both time- and dose-dependent manner. After treatment for 72 h, the cell growth inhibitory rate in 50 μmol/L CGZ (84% ± 11% ) treated cells was found more higher than that in both 40 μmol/L and 30 μmol/L CGZ treated cells (72% ± 13% ,59% ± 13% ,P ＜0.01 ) and a typical DNA ladder was also observed by agarose gel electrophoresis. The expression of PPARγ was gradually up-regulated by CGZ treatment and could be down-regulated partially by PPARγ antagonist GW9662. The results also revealed that CGZ-induced cell apoptosis(49.7% ,72 h)could not be inhibited thoroughly by GW9662 ( 36. 2%, control: 3.2% ). It indicated that the CGZ-induced cell apoptosis was partially PPARγ-independent. Western bloting showed a cleavage of caspase-3 zymogen protein and upregulation of p-P38 protein. Thus it indicated that the activations of caspase-3 and P38 MAPK were involved in CGZ-induced cell apoptosis. Conclusion CGZ inhibits cell growth by induction of cell apoptosis in HL-60 cells via PPARγ dependent and independent signaling pathways. The activations of caspase-3 and P38MAPK may be one of the important mechanisms in CGZ in treated HL-60 cells.

Peroxisome Proliferator-Activated Receptor-Gamma Agonist Rosiglitazone-Induced Apoptosis In Leukemia K562 Cells And Its Mechanisms Of Action

Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone– Induced Apoptosis in Leukemia K562 Cells and Its Mechanisms of Action

Peroxisome Proliferator-Activated Receptor Γ (Ppar-Γ) Agonist Rosiglitazone (RGZ) Inhibits HL-60 Cell Growth by Induction of Apoptosis

Its Mechanisms of Action Induced Apoptosis in Leukemia − Agonist Rosiglitazone γ Peroxisome Proliferator-Activated Receptor -

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

Effect of rosiglitazone on proliferation of U937 cells and its mechanisms

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Mechanistic Study of Peroxisome Proliferator-Activated Receptor γ(PPARγ) Agonist Induced Apoptosis of NB4 Cells

Activation of Peroxisome Proliferator-Activated Receptor-Gamma Induces Apoptosis on Acute Promyelocytic Leukemia Cells Via Downregulation of XIAP.

Anti‐proliferative Effect of Rosiglitazone in the Human T‐lymphocyte Leukaemia Cell Line Jurkat Cells

Effects of PPARγ Ligand Rosiglitazone on AGS Gastric Cancer Cells Growth

Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway

Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner

Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway

[Proliferation and Apoptosis Effect of Rosiglitazone on Human Ovarian Cancer Cell Line SKOV3].

Inhibition Of Lymphoma Cell Proliferation By Peroxisomal Proliferator-Activated Receptor-Gamma Ligands Via Wnt Signaling Pathway

Rosiglitazone Inhibits Lymph Node Metastasis of Non-small Cell Lung Cancer and Induces Apoptosis of Bronchogenic Carcinoma by Down-regulating IGF-1 Expression

Rosiglitazone Inhibits High Glucose-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Through the PI3K/Akt/eNOS Pathway

Effects of Rosiglitazone on Proliferation,apoptosis and Expression of PTEN and Survivin in Liver Cancer Cell Line SMMC-7721

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Apoptosis of Renal Cell Carcinoma